Literature DB >> 21816486

The use of Mood Disorder Questionnaire, Hypomania Checklist-32 and clinical predictors for screening previously unrecognised bipolar disorder in a general psychiatric setting.

Yvette Poon1, Ka-Fai Chung, Kwok-Chu Tso, Chi-Lok Chang, Dorothy Tang.   

Abstract

Bipolar disorder is often unrecognised and misdiagnosed in the general psychiatric setting. This study compared the psychometric properties of the Mood Disorder Questionnaire (MDQ) and the Hypomania Checklist-32 (HCL-32), examined the clinical predictors of bipolar disorder and determined the best approach for screening previously unrecognised bipolar disorder in a general psychiatric clinic. A random sample of 340 non-psychotic outpatients with no previous diagnosis of bipolar disorder completed the MDQ and HCL-32 during their scheduled clinic visits. Mood and alcohol/substance use disorders were reassessed using a telephone-based Structured Clinical Interview for DSM-IV. We found that the HCL-32 had better psychometric performance and discriminatory capacity than the MDQ. The HCL-32's internal consistency and 4-week test-retest reliability were higher. The area under the curve was also greater than that of the MDQ at various clustering and impairment criteria. The optimal cut-off of the MDQ was co-occurrence of four symptoms with omission of the impairment criterion; for the HCL-32, it was 11 affirmative responses. Multivariable logistic regression found that bipolar family history was associated with an increased risk of bipolar disorder (odds ratio=4.93). The study showed that simultaneous use of the HCL-32 and bipolar family history was the best approach for detecting previously unrecognised bipolar disorder. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21816486     DOI: 10.1016/j.psychres.2011.07.014

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  7 in total

1.  Assessment of the diagnostic performance of two new tools versus routine screening instruments for bipolar disorder: a meta-analysis.

Authors:  Mehdi Sayyah; Ali Delirrooyfard; Fakher Rahim
Journal:  Braz J Psychiatry       Date:  2022 May-Jun

Review 2.  Mania: diagnosis and treatment recommendations.

Authors:  Gin S Malhi; Michelle Tanious; Michael Berk
Journal:  Curr Psychiatry Rep       Date:  2012-12       Impact factor: 5.285

3.  Validation of the Chinese version of the "Mood Disorder Questionnaire" for screening bipolar disorder among patients with a current depressive episode.

Authors:  Zhaoyu Gan; Zili Han; Kanglai Li; Feici Diao; Xiaoli Wu; Nianhong Guan; Jinbei Zhang
Journal:  BMC Psychiatry       Date:  2012-01-31       Impact factor: 3.630

4.  Bipolar risk and mental imagery susceptibility in a representative sample of Chinese adults residing in the community.

Authors:  Roger Man-kin Ng; Stephanie Burnett Heyes; Freda McManus; Helen Kennerley; Emily A Holmes
Journal:  Int J Soc Psychiatry       Date:  2015-08-13

5.  Hypomania Symptoms Across Psychiatric Disorders: Screening Use of the Hypomania Check-List 32 at Admission to an Outpatient Psychiatry Clinic.

Authors:  Marta Camacho; Sílvia Almeida; Ana Rita Moura; Ana B Fernandes; Gabriela Ribeiro; Joaquim Alves da Silva; J Bernardo Barahona-Corrêa; Albino J Oliveira-Maia
Journal:  Front Psychiatry       Date:  2018-11-07       Impact factor: 4.157

6.  Predicting Bipolar Disorder Risk Factors in Distressed Young Adults From Patterns of Brain Activation to Reward: A Machine Learning Approach.

Authors:  Leticia de Oliveira; Liana C L Portugal; Mirtes Pereira; Henry W Chase; Michele Bertocci; Richelle Stiffler; Tsafrir Greenberg; Genna Bebko; Jeanette Lockovich; Haris Aslam; Janaina Mourao-Miranda; Mary L Phillips
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-04-17

7.  Screening for Bipolar Disorder Symptoms in Depressed Primary Care Attenders: Comparison between Mood Disorder Questionnaire and Hypomania Checklist (HCL-32).

Authors:  Anna Sasdelli; Loredana Lia; C Claudia Luciano; Claudia Nespeca; Domenico Berardi; Marco Menchetti
Journal:  Psychiatry J       Date:  2013-04-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.